Zerbaxa (ceftolozane/tazobactam) - Merck Sales History and Forecasts

Merck Zerbaxa

Chart

Sales

Snapshot

QoQ

T&Ds

Alerts

US Label

Marketed

Cephalosporin/beta-lactamase combo

Complicated Skin and Skin Structure Infections

Complicated Intra Abdominal Infection

Loading quarterly data...

Consensus

Lower than Low

Lower than Median

Equal

Higher than Median

Higher than High

Actual (No Consensus)

	Median	YOY	High	Low	US	YOY	RoW	YOY

Zerbaxa is also known as CXA-201 and ceftolozane/tazobactam.

Medicare Part B spending of $1m in 2020 represented 0.5% of WW sales.

Excel Plugin ID: DRUG-1502

DrugAnalyst Database